neoplasm
• of the 15% (16 out of 102) of heterozygotes with increased WBC counts 4 had chronic myelocytic leukemia in the chronic phase and the other 12 were in blast crisis
|
hematopoietic system
• this 15% also had splenomegaly
|
• 15% of heterozygotes have decreased RBC counts (6.35 +/- 0.6 x 10 6 cells/mm3 compared to 9.32 +/- 0.04 x 106 cells/mm3 in wild-type mice)
|
• 15% of heterozygotes have increased mean WBC counts (22.3 +/- 5.8 x 10 3 cells/mm3 compared to 8.7 +/- 103 cells/mm3 in wild-type mice)
|
immune system
• this 15% also had splenomegaly
|
• 15% of heterozygotes have increased mean WBC counts (22.3 +/- 5.8 x 10 3 cells/mm3 compared to 8.7 +/- 103 cells/mm3 in wild-type mice)
|
growth/size/body
• this 15% also had splenomegaly
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
chronic myeloid leukemia | DOID:8552 |
OMIM:608232 |
J:97239 |